Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia
- PMID: 20669154
- DOI: 10.1002/hon.959
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia
Abstract
We wish to validate in a multicentric CLL population a nomogram and a risk score recently developed to predict overall survival (OS). Complete records from 1037 CLL patients were retrospectively collected to estimate OS and time to treatment (TTT). Cox models were used to test the independence of age, β-2-microglobulin, absolute lymphocyte count (ALC), sex, Rai stage and number of involved lymph node regions (LNR). Accuracy of prognostic models was tested with the concordance index (c-index). Median follow-up was 5.5 years, with 151 deaths and 475 treated patients. Median OS was not reached (65% survival rate at 13.9 years), median TTT was 6 years. We confirmed the ability of the prognostic score to predict OS and TTT in three risk groups, with results comparable with those reported in the original report. However, ALC and Rai stage were not independent predictors, whereas the Binet staging system, which incorporates LNR variable, showed independent predictive power; furthermore, both 5- and 10-year OS estimates from nomogram were lower compared to real data. When separately analysed, the impact of therapy on OS was not selected as independent predictor of OS in our series. According to these results, we proposed a simpler four-variable model (age, sex, Binet staging, β-2-microglobulin) and a new nomogram. This model had a c-index of 0.78 versus 0.76 of the six-variable model (p = 0.043), showing better predictive accuracy. External validation and refinement are needed on independent data sets, possibly from cancer registry patients' series.
Copyright © 2010 John Wiley & Sons, Ltd.
Similar articles
-
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases.Br J Haematol. 2014 Oct;167(2):224-32. doi: 10.1111/bjh.13032. Epub 2014 Jul 11. Br J Haematol. 2014. PMID: 25041609
-
[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].Acta Med Croatica. 2008 Oct;62(4):351-64. Acta Med Croatica. 2008. PMID: 19205412 Croatian.
-
Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.Am J Surg Pathol. 2011 Nov;35(11):1646-56. doi: 10.1097/PAS.0b013e31822d63a7. Am J Surg Pathol. 2011. PMID: 21997685
-
Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.Ann Hematol. 2011 Oct;90(10):1123-9. doi: 10.1007/s00277-011-1259-3. Epub 2011 May 26. Ann Hematol. 2011. PMID: 21614458 Review.
-
Prognostic factors in chronic lymphocytic leukemia.Leukemia. 1997 Apr;11 Suppl 2:S4-13. Leukemia. 1997. PMID: 9178831 Review.
Cited by
-
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.J Transl Med. 2012 Jan 30;10:18. doi: 10.1186/1479-5876-10-18. J Transl Med. 2012. PMID: 22289136 Free PMC article.
-
Prognostic Factors in the Era of Targeted Therapies in CLL.Curr Hematol Malig Rep. 2018 Apr;13(2):78-90. doi: 10.1007/s11899-018-0439-9. Curr Hematol Malig Rep. 2018. PMID: 29473123 Review.
-
Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.Cochrane Database Syst Rev. 2020 Jul 31;7(7):CD012022. doi: 10.1002/14651858.CD012022.pub2. Cochrane Database Syst Rev. 2020. PMID: 32735048 Free PMC article.
-
Clinical implications of the molecular genetics of chronic lymphocytic leukemia.Haematologica. 2013 May;98(5):675-85. doi: 10.3324/haematol.2012.069369. Haematologica. 2013. PMID: 23633543 Free PMC article. Review.
-
The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.Biomed Res Int. 2018 Mar 15;2018:9506979. doi: 10.1155/2018/9506979. eCollection 2018. Biomed Res Int. 2018. PMID: 29736400 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials